#neurological — Wednesday, May 20, 2026 (1 items)
| 0 | 💬 0 |
Dolutegravir Reduces Human T-Cell Lymphotropic Virus Type 1 Proviral Load and Improves Neurological Outcomes in a Phase 2 Controlled Trial.
(academic.oup.com)
|
Clinical Infectious Diseases 2026-05-20 | #clinical trial #antiviral #virology #neurological #htlv-1 |